-
1
-
-
0037490080
-
Quantifying effect of statins on low-density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis
-
M.R. Law, N.J. Wald, and A.R. Rudnicka Quantifying effect of statins on low-density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis BMJ 326 2003 1423 1430
-
(2003)
BMJ
, vol.326
, pp. 1423-1430
-
-
Law, M.R.1
Wald, N.J.2
Rudnicka, A.R.3
-
2
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., and J.J. Kastelein Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto Jr., A.M.5
Kastelein, J.J.6
-
3
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
4
-
-
0037840242
-
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised, placebo-controlled trial
-
R. Collins, J. Armitage, S. Parish, P. Sleigh, and R. Peto MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised, placebo-controlled trial Lancet 361 2003 2005 2016
-
(2003)
Lancet
, vol.361
, pp. 2005-2016
-
-
Collins, R.1
Armitage, J.2
Parish, S.3
Sleigh, P.4
Peto, R.5
-
5
-
-
48249093075
-
Lipid screening and cardiovascular health in childhood
-
S.R. Daniels, and F.R. Greer Lipid screening and cardiovascular health in childhood Pediatrics 122 2008 198 208
-
(2008)
Pediatrics
, vol.122
, pp. 198-208
-
-
Daniels, S.R.1
Greer, F.R.2
-
6
-
-
52649142138
-
Storm over statins: The controversy surrounding pharmacologic treatment of children
-
F.S. de Ferranti, and D.S. Ludwig Storm over statins: the controversy surrounding pharmacologic treatment of children N Engl J Med 359 2008 1309 1312
-
(2008)
N Engl J Med
, vol.359
, pp. 1309-1312
-
-
De Ferranti, F.S.1
Ludwig, D.S.2
-
7
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, and C. Pollicino Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
Blackwell, L.4
Buck, G.5
Pollicino, C.6
-
8
-
-
34547645389
-
A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia
-
DOI 10.1161/ATVBAHA.107.145151, PII 0004360520070800000020
-
H.J. Avis, M.N. Vissers, E.A. Stein, F.A. Wijburg, M.D. Trip, and J.J. Kastelein A systematic review and meta-analysis (Pubitemid 47207177)
-
(2007)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.27
, Issue.8
, pp. 1803-1810
-
-
Avis, H.J.1
Vissers, M.N.2
Stein, E.A.3
Wijburg, F.A.4
Trip, M.D.5
Kastelein, J.J.P.6
Hutten, B.A.7
-
9
-
-
0026448725
-
The discovery and development of HMG-CoA reductase inhibitors
-
A. Endo The discovery and development of HMG-CoA reductase inhibitors J Lipid Res 33 1992 1569 1582
-
(1992)
J Lipid Res
, vol.33
, pp. 1569-1582
-
-
Endo, A.1
-
10
-
-
0012953543
-
The regulation of the synthesis of coenzyme Q in fibroblasts and in heart muscle
-
H. Rudney The regulation of the synthesis of coenzyme Q in fibroblasts and in heart muscle K. Folkers, Y. Yamamura, Biomedical Aspects of Coenzyme Q 1981 Elsevier Science Amsterdam 279 290
-
(1981)
Biomedical Aspects of Coenzyme Q
, pp. 279-290
-
-
Rudney, H.1
-
11
-
-
0029042393
-
Biochemical, physiological and medical aspects of ubiquinone function
-
L. Ernster, and G. Dallner Biochemical, physiological and medical aspects of ubiquinone function Biochim Biophys Acta 1271 1995 195 204
-
(1995)
Biochim Biophys Acta
, vol.1271
, pp. 195-204
-
-
Ernster, L.1
Dallner, G.2
-
12
-
-
0027234508
-
Ubiquinol: An endogenous antioxidant in aerobic organisms
-
L. Ernster, and P. Forsmark-Andree Ubiquinol: an endogenous antioxidant in aerobic organisms Clin Investig 71 1993 S60 S65
-
(1993)
Clin Investig
, vol.71
-
-
Ernster, L.1
Forsmark-Andree, P.2
-
13
-
-
0141610413
-
Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy
-
DOI 10.1073/pnas.86.7.2379
-
S. Ogasahara, A.G. Engel, D. Frens, and D. Mack Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy Proc Natl Acad Sci USA 86 1989 2379 2382 (Pubitemid 19102512)
-
(1989)
Proceedings of the National Academy of Sciences of the United States of America
, vol.86
, Issue.7
, pp. 2379-2382
-
-
Ogasahara, S.1
Engel, A.G.2
Frens, D.3
Mack, D.4
-
14
-
-
0030975555
-
10 deficiency
-
C. Sobreira, M. Hirano, S. Shanske, R.K. Keller, R.G. Haller, and E. Davidson Mitochondrial encephalomyopathy with coenzyme Q10 deficiency Neurology 48 1997 1238 1243 (Pubitemid 27240541)
-
(1997)
Neurology
, vol.48
, Issue.5
, pp. 1238-1243
-
-
Sobreira, C.1
Hirano, M.2
Shanske, S.3
Keller, R.K.4
Haller, R.G.5
Davidson, E.6
Santorelli, F.M.7
Miranda, A.F.8
Bonilla, E.9
Mojon, D.S.10
Barreira, A.A.11
King, M.P.12
DiMauro, S.13
-
15
-
-
0034730011
-
10 deficiency
-
A. Rotig, E.L. Appelkvist, V. Geromel, D. Chretien, N. Kadhom, and P. Edery Quinone-responsive multiple respiratory chain dysfunction due to widespread coenzyme Q10 deficiency Lancet 356 2000 391 395 (Pubitemid 30487496)
-
(2000)
Lancet
, vol.356
, Issue.9227
, pp. 391-395
-
-
Rotig, A.1
Appelkvist, E.-L.2
Geromel, V.3
Chretien, D.4
Kadhom, N.5
Edery, P.6
Lebideau, M.7
Dallner, G.8
Munnich, A.9
Ernster, L.10
Rustin, P.11
-
16
-
-
77749310839
-
Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia
-
H.J. Avis, B.A. Hutten, C. Gagné, G. Langslet, B.W. McCrindle, and A. Wiegman Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia J Am Coll Cardiol 55 2010 1121 1126
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1121-1126
-
-
Avis, H.J.1
Hutten, B.A.2
Gagné, C.3
Langslet, G.4
McCrindle, B.W.5
Wiegman, A.6
-
17
-
-
28044432748
-
10 as an internal standard
-
DOI 10.1373/clinchem.2005.054643
-
A.J. Duncan, S.J. Heales, K. Mills, S. Eaton, J.M. Land, and I.P. Hargreaves Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard Clin Chem 51 2005 2380 2382 (Pubitemid 41692590)
-
(2005)
Clinical Chemistry
, vol.51
, Issue.12
, pp. 2380-2382
-
-
Duncan, A.J.1
Heales, S.J.R.2
Mills, K.3
Eaton, S.4
Land, J.M.5
Hargreaves, I.P.6
-
19
-
-
0027238928
-
Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts: Application to mitochondrial encephalomyopathies
-
DOI 10.1016/0925-4439(93)90024-U
-
R.J. Wanders, J.P. Ruiter, and F.A. Wijburg Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts: application to mitochondrial encephalomyopathies Biochim Biophys Acta 1181 1993 219 222 (Pubitemid 23177211)
-
(1993)
Biochimica et Biophysica Acta - Molecular Basis of Disease
, vol.1181
, Issue.3
, pp. 219-222
-
-
Wanders, R.J.A.1
Ruiter, J.P.N.2
Wijburg, F.A.3
-
20
-
-
0018337607
-
Assay of citric acid cycle intermediates and related compounds: Update with tissue metabolite levels and intracellular distribution
-
J.R. Williamson, and B.E. Corkey Assay of citric acid cycle intermediates and related compounds: update with tissue metabolite levels and intracellular distribution Methods Enzymol 55 1979 200 222
-
(1979)
Methods Enzymol
, vol.55
, pp. 200-222
-
-
Williamson, J.R.1
Corkey, B.E.2
-
21
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
22
-
-
0034822296
-
10 deficiency
-
DOI 10.1067/mpd.2001.117575
-
S. Rahman, I. Hargreaves, P. Clayton, and S. Heales Neonatal presentation of coenzyme Q10 deficiency J Pediatr 139 2001 456 458 (Pubitemid 32889527)
-
(2001)
Journal of Pediatrics
, vol.139
, Issue.3
, pp. 456-458
-
-
Rahman, S.1
Hargreaves, I.2
Clayton, P.3
Heales, S.4
-
23
-
-
21844435776
-
High-dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial
-
DOI 10.1016/j.clpt.2005.03.006, PII S0009923605001359
-
H. Paiva, K.M. Thelen, C.R. Van, J. Smet, P.B. De, and K.M. Mattila High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial Clin Pharmacol Ther 78 2005 60 68 (Pubitemid 40956932)
-
(2005)
Clinical Pharmacology and Therapeutics
, vol.78
, Issue.1
, pp. 60-68
-
-
Paiva, H.1
Thelen, K.M.2
Van Coster, R.3
Smet, J.4
De Paepe, B.5
Mattila, K.M.6
Laakso, J.7
Lehtimaki, T.8
Von Bergmann, K.9
Lutjohann, D.10
Laaksonen, R.11
-
24
-
-
23644449084
-
10: Possible biochemical/clinical implications
-
DOI 10.2165/00002018-200528080-00002
-
I.P. Hargreaves, A.J. Duncan, S.J. Heales, and J.M. Land The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications Drug Saf 28 2005 659 676 (Pubitemid 41132454)
-
(2005)
Drug Safety
, vol.28
, Issue.8
, pp. 659-676
-
-
Hargreaves, I.P.1
Duncan, A.J.2
Heales, S.J.R.3
Land, J.M.4
-
25
-
-
0033067363
-
10 ratio as a possible marker of increased risk for atherosclerosis
-
M. Tomasetti, R. Alleva, M.D. Solenghi, and G.P. Littarru Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis Biofactors 9 1999 231 240 (Pubitemid 29289001)
-
(1999)
BioFactors
, vol.9
, Issue.2-4
, pp. 231-240
-
-
Tomasetti, M.1
Alleva, R.2
Solenghi, M.D.3
Littarru, G.P.4
-
26
-
-
0026465910
-
Plasma ubiquinone, alpha-tocopherol and cholesterol in man
-
J. Karlsson, B. Diamant, P.O. Edlund, B. Lund, K. Fokers, and H. Theorell Plasma ubiquinone, alpha-tocopherol and cholesterol in man Int J Vitam Nurtr Res 62 1992 160 164
-
(1992)
Int J Vitam Nurtr Res
, vol.62
, pp. 160-164
-
-
Karlsson, J.1
Diamant, B.2
Edlund, P.O.3
Lund, B.4
Fokers, K.5
Theorell, H.6
-
27
-
-
26944451510
-
10 level in statin-related myopathy
-
DOI 10.1001/archneur.62.11.1709
-
C. Lamperti, A.B. Naini, V. Lucchini, A. Prelle, N. Bresolin, and M. Moggio Muscle coenzyme Q10 level in statin-related myopathy Arch Neurol 62 2005 1709 1712 (Pubitemid 41626667)
-
(2005)
Archives of Neurology
, vol.62
, Issue.11
, pp. 1709-1712
-
-
Lamperti, C.1
Naini, A.B.2
Lucchini, V.3
Prelle, A.4
Bresolin, N.5
Moggio, M.6
Sciacco, M.7
Kaufmann, P.8
DiMauro, S.9
-
28
-
-
57149086339
-
Decreased upiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment
-
A.J. Duncan, I.P. Hargreaves, M.S. Damian, J.M. Land, and S.J. Heales Decreased upiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment Toxicol Mech Methods 19 2009 44 50
-
(2009)
Toxicol Mech Methods
, vol.19
, pp. 44-50
-
-
Duncan, A.J.1
Hargreaves, I.P.2
Damian, M.S.3
Land, J.M.4
Heales, S.J.5
-
29
-
-
34247639532
-
Effect of Coenzyme Q10 on Myopathic Symptoms in Patients Treated With Statins
-
DOI 10.1016/j.amjcard.2006.12.063, PII S000291490700255X
-
G. Caso, P. Kelly, M.A. McNurlan, and W.E. Lawson Effect of coenzyme q10 on myopathic symptoms in patients treated with statins Am J Cardiol 15 2007 1409 1412 (Pubitemid 46686635)
-
(2007)
American Journal of Cardiology
, vol.99
, Issue.10
, pp. 1409-1412
-
-
Caso, G.1
Kelly, P.2
McNurlan, M.A.3
Lawson, W.E.4
-
30
-
-
35348863203
-
10 Supplementation on Simvastatin-Induced Myalgia
-
DOI 10.1016/j.amjcard.2007.06.030, PII S0002914907014579
-
J.M. Young, C.M. Florkowski, S.L. Molyneux, R.G. McEwan, C.M. Frampton, and P.M. George Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia Am J Cardiol 100 2007 1400 1403 (Pubitemid 47576018)
-
(2007)
American Journal of Cardiology
, vol.100
, Issue.9
, pp. 1400-1403
-
-
Young, J.M.1
Florkowski, C.M.2
Molyneux, S.L.3
McEwan, R.G.4
Frampton, C.M.5
George, P.M.6
Scott, R.S.7
-
31
-
-
57649095363
-
Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients
-
W. Ahmend, N. Khan, C.J. Glueck, S. Pandey, P. Wang, and N. Goldenberg Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients Transl Res 153 2009 11 16
-
(2009)
Transl Res
, vol.153
, pp. 11-16
-
-
Ahmend, W.1
Khan, N.2
Glueck, C.J.3
Pandey, S.4
Wang, P.5
Goldenberg, N.6
|